Statement re Share Price Movement

PROTEOME SCIENCES plc

("Proteome Sciences" or the "Company")

 

PRESS RELEASE

 
Statement re Share Price Movement

 
The Board of Proteome Sciences has noted the recent movement in the Company's
share price and that they are not aware of any reason for the share price
increase.


In the trading update released on 21 December 2007, the Board reported that it
continued to view future prospects for TMT® commercialisation with increasing
confidence, with the related licence negotiations expected to be concluded in
early 2008.  This remains the case and the Company will issue a further update
on licence negotiations in due course.

 

                                     Ends                                      

                                                                               

For further information please visit www.proteomics.com.

 

Proteome Sciences plc

 

Christopher Pearce                       James Malthouse

Chief Executive Officer                  Finance Director

[e-mail]        [e-mail]

 

Tel: [phone]

 

                               Public Relations                                

 

IKON Associates                          Coast Communications

Adrian Shaw                              Matt Baldwin

Tel:    [phone]               Tel:    [phone]

Mobile: [phone]               Mobile: [phone]

[e-mail]                [e-mail]

 

 

Nominated Adviser

Landsbanki Securities (UK) Limited

Gareth Price / Thilo Hoffman             Tel:    [phone]